169 related articles for article (PubMed ID: 28165818)
1. Investigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid technique.
Khames A
Drug Deliv; 2017 Nov; 24(1):328-338. PubMed ID: 28165818
[TBL] [Abstract][Full Text] [Related]
2. Solubility enhancement effect at absorption site on bioavailability of ritonavir using liquisolid technique.
Bonthagarala B; Dasari V; Kotra V
Ther Deliv; 2019 May; 10(5):295-310. PubMed ID: 31094300
[No Abstract] [Full Text] [Related]
3. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Oral Bioavailability of Etodolac by the Liquisolid Compact Technique: Optimisation, In-Vitro and In-Vivo Evaluation.
Pathak BK; Raghav M; Thakkar AR; Vyas BA; Shah PJ
Curr Drug Deliv; 2021; 18(4):471-486. PubMed ID: 33106143
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
Fahmy RH; Kassem MA
Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.
Chen B; Wang Z; Quan G; Peng X; Pan X; Wang R; Xu Y; Li G; Wu C
Int J Nanomedicine; 2012; 7():199-209. PubMed ID: 22275835
[TBL] [Abstract][Full Text] [Related]
7. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
[TBL] [Abstract][Full Text] [Related]
8. Effects of liquisolid formulations on dissolution of naproxen.
Tiong N; Elkordy AA
Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
[TBL] [Abstract][Full Text] [Related]
9. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.
Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P
Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418
[TBL] [Abstract][Full Text] [Related]
10. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
[TBL] [Abstract][Full Text] [Related]
11. Liqui-Pellet: the Emerging Next-Generation Oral Dosage Form Which Stems from Liquisolid Concept in Combination with Pelletization Technology.
Lam M; Ghafourian T; Nokhodchi A
AAPS PharmSciTech; 2019 Jun; 20(6):231. PubMed ID: 31236781
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone release from liquisolid formulations prepared with Capryol™ 90, Solutol® HS-15 and Kollicoat® SR 30 D as non-volatile liquid vehicles.
Elkordy AA; Tan XN; Essa EA
Eur J Pharm Biopharm; 2013 Feb; 83(2):203-23. PubMed ID: 22960707
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of ketoconazole dissolution rate by the liquisolid technique.
Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y
Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692
[TBL] [Abstract][Full Text] [Related]
14. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
Tayel SA; Soliman II; Louis D
Eur J Pharm Biopharm; 2008 May; 69(1):342-7. PubMed ID: 17949959
[TBL] [Abstract][Full Text] [Related]
15. Liquisolid Technology: A State-of-the-Art Review on the Current State, Challenges, New and Emerging Technologies for Next Generation.
Agiba AM
Curr Drug Deliv; 2020; 17(9):736-754. PubMed ID: 32729418
[TBL] [Abstract][Full Text] [Related]
16. Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release.
El-Hammadi M; Awad N
AAPS PharmSciTech; 2012 Mar; 13(1):53-8. PubMed ID: 22101967
[TBL] [Abstract][Full Text] [Related]
17. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
Javadzadeh Y; Musaalrezaei L; Nokhodchi A
Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
[TBL] [Abstract][Full Text] [Related]
18. Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation.
Jaipakdee N; Limpongsa E; Sripanidkulchai BO; Piyachaturawat P
Int J Pharm; 2018 Dec; 553(1-2):157-168. PubMed ID: 30316793
[TBL] [Abstract][Full Text] [Related]
19. Design of mirtazapine solid dispersion with different carriers' systems: optimization, in vitro evaluation, and bioavailability assessment.
Aldeeb RAE; Mahdy MAE; El-Nahas HM; Musallam AA
Drug Deliv Transl Res; 2023 Sep; 13(9):2340-2352. PubMed ID: 36940079
[TBL] [Abstract][Full Text] [Related]
20. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
Khanfar M; Sheikh Salem M; Hawari R
Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
